Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab

被引：0
|
作者：
Huezin H. Lim
Ashley M. Hopkins
Andrew Rowland
Hoi Y. Yuen
Christos S. Karapetis
Michael J. Sorich
机构：
[1] Flinders University,College of Medicine and Public Health
来源：
Targeted Oncology | 2019年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：743 / 748
页数：5
相关论文
共 50 条
  • [1] Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab
    Lim, Huezin H.
    Hopkins, Ashley M.
    Rowland, Andrew
    Yuen, Hoi Y.
    Karapetis, Christos S.
    Sorich, Michael J.
    [J]. TARGETED ONCOLOGY, 2019, 14 (06) : 743 - 748
  • [2] Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
    Logan, Jessica M.
    Brooks, Doug A.
    Rowland, Andrew
    Sorich, Michael J.
    Hopkins, Ashley M.
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [3] Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
    Meng, Lingbin
    Thapa, Ram
    Delgado, Maria G.
    Gomez, Maria F.
    Ji, Rui
    Knepper, Todd C.
    Hubbard, Joleen M.
    Wang, Xuefeng
    Permuth, Jennifer B.
    Kim, Richard D.
    Laber, Damian A.
    Xie, Hao
    [J]. JAMA NETWORK OPEN, 2023, 6 (06) : E2320035
  • [4] ADVERSE EVENTS AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH MONOCLONAL ANTIBODIES IN CLINICAL PRACTICE
    Emons, M. F.
    Dean, B.
    Yu, H. T.
    Barber, B.
    Malin, J.
    Zhao, Z.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A435 - A435
  • [5] Economics of ramucirumab for metastatic colorectal cancer
    Zeichner, Simon B.
    Kohn, Christine G.
    Goldstein, Daniel A.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 733 - 745
  • [6] Survival outcomes in US patients with metastatic colorectal cancer (mCRC)
    Knopf, Kevin
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Malangone, Elisabetta
    Gorritz-Kindu, Magdaliz
    Stern, Lee
    Sherman, Steven A.
    Naoshy, Sarah
    Wooten, Michael
    Andria, Michael L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [7] HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCER
    Fu, A. Z.
    Zhao, Z.
    Wang, S.
    Gao, S.
    Barber, B.
    Liu, G.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A173 - A173
  • [8] Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
    Shankaran, Veena
    Mummy, David
    Koepl, Lisel
    Blough, David
    Yim, Yeun Mi
    Yu, Elaine
    Ramsey, Scott
    [J]. CLINICAL COLORECTAL CANCER, 2013, 12 (03) : 204 - +
  • [9] Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology
    Cartwright, Thomas H.
    Yim, Yeun Mi
    Yu, Elaine
    Chung, Hsingwen
    Halm, Melissa
    Forsyth, Michael
    [J]. CLINICAL COLORECTAL CANCER, 2012, 11 (04) : 238 - 246
  • [10] Drug holidays and overall survival in patients treated for metastatic colorectal cancer
    Garattini, S. K.
    Bonotto, M.
    Basile, D.
    Porcu, L.
    Ongaro, E.
    Gerratana, L.
    Cortiula, F.
    Pelizzari, G.
    Parnofiello, A.
    Bertoli, E.
    Corvaja, C.
    Lisanti, C.
    Casagrande, M.
    Iacono, D.
    Cardellino, G. G.
    Buonadonna, A.
    Aprile, G.
    Pella, N.
    Puglisi, F.
    Fasola, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 219 - 219
12345